Common Contracts

1 similar Collaborative R&d Agreement contracts

Collaborative R&D agreement for antibody-drug conjugate (ADC) technology with antibodies to a single oncology target
Collaborative R&d Agreement • May 28th, 2021

Abbott Laboratories will pay a $25 million upfront fee to Seattle Genetics for expanded rights to utilize Seattle Genetics' technology for cancer.